Cloud-Connected Bioreactors: Optimizing Synthetic Biology Scale-Up

Healthcare > Pharmaceutical11/12/2024 6:00 PM

Go to Registration Page

Description

While synthetic biology has considerably advanced in the past decade, cost continues to be a major factor in commercial viability. Saccharomyces cerevisiae is a commonly used microbial host in synthetic biology. These cultures can be grown to very high densities with high expression levels of target molecules, making S. cerevisiae a preferred candidate for cost-effective natural product synthesis.

In this webinar, the expert speakers demonstrate the seamless scale-up of a high-yield fermentation process from 250 mL to 5 L, enabled by extensive vessel characterization using cloud-connected bioreactors. The speakers will share insights into how utilizing S. cerevisiae provided an efficient and cost-effective scale-up method.

They will also present case studies that illustrate the steps taken to reduce costs and mitigate risks during the scale-up process. The attendees will also gain a comprehensive understanding of how cloud-connected bioreactors can dramatically accelerate the scale-up process in biomanufacturing. The speakers will then delve into practical troubleshooting methods, designed to address and overcome common challenges encountered during scale-up.

Moreover, the session will explore effective strategies for reducing costs and de-risking the scale-up process, equipping attendees with tools and knowledge needed to optimize production efficiency and ensure successful outcomes in their biomanufacturing projects.

Register for this webinar to discover how cloud-connected bioreactors are revolutionizing the scale-up process for biomanufacturing.

What You Will Learn

Attendees will learn about:

• How cloud-connected bioreactors can accelerate scale-up

• Troubleshooting methods to overcome scale-up challenges

• Strategies for reducing costs and de-risking scale-up

Who Should Attend?

This webinar will appeal to:

• Small-Mid-Large Biotech/Pharma

• Emerging biotechs and startups/Agricultural biotechnology firms

• Food Technology and fermentation-based food companies

• Biofuel and renewable chemical companies

• Research institutions and academia

• Bioprocess Engineers

• Head of Process Development/Innovation

• Upstream Process Development Scientists

• Formulation Scientists

• Product Development

• Consultants/R&D/Scientists/Formulators

Speakers: Andrew Horwitz, PhD, Vice President Research and Development, Inscripta; Kris Tyner, Senior Director, Bioprocess Sciences, Culture Biosciences.


Comments

Publisher

Xtalks

Xtalks

Xtalks is a digital platform that delivers webinars, news, videos, and job postings to the healthcare and FDA and EMA regulated industries. With a focus on the life sciences, medical devices, food, and healthcare sectors, Xtalks aims to connect industry professionals and provide valuable content and resources to its community members.